Sun Minqiong, Tan Zhenya, Lin Keqiong, Li Xiaofei, Zhu Jicheng, Zhan Li, Zheng Hong
Department of Pathophysiology, Anhui Medical University, Hefei, Anhui, China.
Stem Cell Rev Rep. 2023 Oct;19(7):2109-2119. doi: 10.1007/s12015-023-10578-2. Epub 2023 Jun 23.
Current understanding of the leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) in intestinal stem cells (ISCs) is well established, however, the implications of ISC heterogeneity and homeostasis are poorly understood. Prior studies have provided important evidence for the association between heterogeneity of ISC pools with pathogenesis and therapeutic response of malignant disease. Leveraging the advantages of organoids and single cell RNA sequencing (scRNA-seq), glandular development has been simulated and cell heterogeneity has been clarified. Based on this research, several potential ISCs were identified, such as LGR5 + p27 + quiescent ISCs, LGR5 + Mex3a + slowly proliferating stem cells, and CLU + reverse stem cells. We also illustrated major factors responsible for ISC homeostasis including metabolism-related (LKB1, TGR5, HMGCS2), inflammation-related (IFB-b, IFN2, TNF), and Wnt signaling-related (CREPT, Mex3a, MTG16) factors. ISCs play complex roles in intestinal tumorigenesis, chemoresistance and occasional relapse of colon cancer, which bear discussion. In this review, we focus on novel technical challenges in ISCs fate drawing upon recent research with the goals of clarifying our understanding of complex ISCs, elucidating the integrated intestinal crypt niche, and creating new opportunities for therapeutic development.
目前,人们对肠道干细胞(ISC)中富含亮氨酸重复序列的G蛋白偶联受体5(LGR5)已有充分了解,然而,ISC异质性和内稳态的影响却知之甚少。先前的研究为ISC库的异质性与恶性疾病的发病机制和治疗反应之间的关联提供了重要证据。利用类器官和单细胞RNA测序(scRNA-seq)的优势,模拟了腺管发育并阐明了细胞异质性。基于这项研究,确定了几种潜在的ISC,如LGR5 + p27 + 静止ISC、LGR5 + Mex3a + 缓慢增殖干细胞和CLU + 逆向干细胞。我们还阐述了负责ISC内稳态的主要因素,包括代谢相关(LKB1、TGR5、HMGCS2)、炎症相关(IFB-b、IFN2、TNF)和Wnt信号相关(CREPT、Mex3a、MTG16)因素。ISC在肠道肿瘤发生、化疗耐药性和结肠癌偶尔复发中发挥着复杂作用,值得探讨。在这篇综述中,我们基于最近的研究,关注ISC命运中的新技术挑战,目标是阐明我们对复杂ISC的理解,阐明整合的肠道隐窝生态位,并为治疗开发创造新机会。